Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 36

Sort by

Sort Order Select

Journal Articles

Outcomes of Patients with Chronic Lymphocytic Leukemia (CLL) Treated with the Combination of Ibrutinib (I) and Venetoclax (V; I+V) after Progression on I Alone (V-naïve) or after Progression on Sequential I and V (Double-Refractory)

Blood (2021) 138 (Supplement 1): 1560.

https://doi.org/10.1182/blood-2021-151668

Published: 2021

Journal Articles

The CLL International Prognostic Index predicts outcomes in monoclonal B-cell lymphocytosis and Rai 0 CLL

Sameer A. Parikh, Kari G. Rabe, Neil E. Kay, Timothy G. Call, Wei Ding, Jose F. Leis, Saad S. Kenderian, Eli Muchtar, Yucai Wang, Amber B. Koehler, Susan M. Schwager, Connie E. Lesnick, Geffen Kleinstern, Daniel Van Dyke, Curtis A. Hanson, Esteban Braggio, Susan L. Slager, Tait D. Shanafelt

Blood (2021) 138 (2): 149–159.

https://doi.org/10.1182/blood.2020009813

Published: 2021

Includes: Supplemental data

Journal Articles

Venetoclax Has Modest Efficacy in the Treatment of Patients with Relapsed T-Cell Prolymphocytic Leukemia

Paul J. Hampel, MD, Sameer A. Parikh, MD, Timothy G. Call, MD, Mithun Vinod Shah, MD PhD, Nabila Bennani, MD, Aref Al-Kali, MD, Kari G Rabe, Yucai Wang, MDPhD, Eli Muchtar, MD, Jose F. Leis, MD PhD, Saad S. Kenderian, MB, ChB, Amber B. Koehler, PA-C, MS, Susan M. Schwager, Daniel L. Van Dyke, PhD, Susan L. Slager, PhD, Neil E. Kay, MD, Min Shi, MDPhD, Wei Ding, MD PhD

Blood (2020) 136 (Supplement 1): 39–40.

https://doi.org/10.1182/blood-2020-134586

Published: 2020

Journal Articles

Clinical Characteristics and Outcomes of Newly Diagnosed Patients with Chronic Lymphocytic Leukemia Who Are 80 Years of Age or Older

Paul J. Hampel, MD, Timothy G. Call, MD, Kari G Rabe, Sara J. Achenbach, Eli Muchtar, MD, Saad S. Kenderian, MB, ChB, Yucai Wang, MDPhD, Amber B. Koehler, PA-C, MS, Jose F. Leis, MD PhD, Susan M. Schwager, Daniel L. Van Dyke, PhD, Min Shi, MDPhD, Curtis A. Hanson, MD, Tait Shanafelt, MD, Esteban Braggio, PhD, Susan L. Slager, PhD, Neil E. Kay, MD, Wei Ding, MD PhD, Sameer A. Parikh, MD

Blood (2020) 136 (Supplement 1): 26–27.

https://doi.org/10.1182/blood-2020-137578

Published: 2020

Journal Articles

Impact of Deletion6q23 Identified By FISH in Patients with Chronic Lymphocytic Leukemia

Blood (2020) 136 (Supplement 1): 12–13.

https://doi.org/10.1182/blood-2020-139068

Published: 2020

Journal Articles

BTK and/or PLCG2 Mutations in Patients with Chronic Lymphocytic Leukemia (CLL) Treated with Ibrutinib: Characteristics and Outcomes at the Time of Progression

Paul J. Hampel, MD, Timothy G. Call, MD, Sara J. Achenbach, Kari G Rabe, Wei Ding, MD PhD, Eli Muchtar, MD, Saad S. Kenderian, MD, Yucai Wang, MD PhD, Amber Koehler, PA-C, MS, Amie Fonder, PA-C, MS, Jose F. Leis, MD PhD, Susan M. Schwager, Daniel L. Van Dyke, PhD, Esteban Braggio, PhD, Susan L. Slager, PhD, Neil E. Kay, MD, Sameer A. Parikh, MD

Blood (2019) 134 (Supplement_1): 3050.

https://doi.org/10.1182/blood-2019-125411

Published: 2019

Journal Articles

The Role of Imaging in Predicting Time to First Treatment and Overall Survival in Individuals with CLL-like High Count Monoclonal B-Cell Lymphocytosis

William J Archibald, MDCPA, Timothy G. Call, MD, Sara J. Achenbach, Kari G Rabe, Curtis A. Hanson, MD, Wei Ding, MD PhD, Amber Koehler, PA-C, MS, Eli Muchtar, MD, Suzanne R. Hayman, MD, Saad S. Kenderian, MD, Jose F. Leis, MD PhD, Yucai Wang, MD PhD, Amie Fonder, PA-C, MS, Min Shi, MD PhD, Daniel L. Van Dyke, PhD, Susan M. Schwager, Susan L. Slager, PhD, Neil E. Kay, MD, Sameer A. Parikh, MD

Blood (2019) 134 (Supplement_1): 3037.

https://doi.org/10.1182/blood-2019-131154

Published: 2019

Journal Articles

Clinical Characteristics and Outcomes of Chronic Lymphocytic Leukemia Patients with Richter Transformation

Yucai Wang, MD, Marcella Tschautscher, MD, Kari G. Chaffee, MS, Timothy G. Call, MD, Jose F. Leis, MD PhD, Saad S. Kenderian, MD, Neil E. Kay, MD, Eli Muchtar, MD, Daniel L. Van Dyke, PhD, Susan M. Schwager, Susan L. Slager, PhD, Sameer A. Parikh, MD, Wei Ding, MD PhD

Blood (2018) 132 (Supplement 1): 1857.

https://doi.org/10.1182/blood-2018-99-113127

Published: 2018

Journal Articles

The Role of Splenectomy in the Care and Treatment of the CLL Patient

Michael J Conte, PA-C, Sameer A. Parikh, MD, Deborah A. Bowen, APRN, CNP, Timothy G. Call, MD, Brian F Kabat, Kari G Chaffee, MS, Susan M. Schwager, Susan L. Slager, PhD, Wei Ding, MD PhD, Neil E. Kay, MD, Tait D. Shanafelt, MD

Blood (2016) 128 (22): 5575.

https://doi.org/10.1182/blood.V128.22.5575.5575

Published: 2016

Journal Articles

Liver Dysfunction in Previously Untreated Chronic Lymphocytic Leukemia: Prevalence and Outcomes in a Large Cohort

Paul J Hampel, MD, Kari G. Chaffee, MS, Simonetto A Douglas, MD, Timothy G. Call, MD, Wei Ding, MD PhD, Saad S Kenderian, MD, Jose F. Leis, MD, PhD, Asher A. Chanan-Khan, MD, Deborah A. Bowen, APRN, CNP, Michael J Conte, PA-C, Sara J Achenbach, Susan M. Schwager, Susan L. Slager, PhD, Neil E. Kay, MD, Tait D. Shanafelt, MD, Sameer A. Parikh, MD

Blood (2016) 128 (22): 5585.

https://doi.org/10.1182/blood.V128.22.5585.5585

Published: 2016

Journal Articles

Clinically Ascertained Monoclonal B-Cell Lymphocytosis: Risk of Progression to Chronic Lymphocytic Leukemia Requiring Therapy and Outcomes

Sameer A. Parikh, MD, Kari G Chaffee, MS, Timothy G. Call, MD, Jose F. Leis, MD, PhD, Wei Ding, MD PhD, Saad S Kenderian, MD, Asher A. Chanan-Khan, MD, Deborah A. Bowen, APRN, CNP, Michael J Conte, PA-C, Susan M. Schwager, Susan L. Slager, PhD, Curtis A. Hanson, MD, Neil E. Kay, MD, Tait D. Shanafelt, MD

Blood (2016) 128 (22): 3228.

https://doi.org/10.1182/blood.V128.22.3228.3228

Published: 2016

Journal Articles

Ibrutinib Therapy for Chronic Lymphocytic Leukemia (CLL): An Analysis of a Large Cohort of Patients Treated in Routine Clinical Practice

Sameer A. Parikh, MD, Kari Rabe Chaffee, MS, Timothy G. Call, MD, Wei Ding, MD PhD, Jose F. Leis, MD PhD, Asher Chanan-Khan, MD, Deborah A. Bowen, APRN, CNP, Michael Conte, PA-C, Daniel L. Van Dyke, PhD, Curtis A. Hanson, MD, Susan M. Schwager, Susan L. Slager, PhD, Neil E. Kay, MD, Tait D. Shanafelt, MD

Blood (2015) 126 (23): 2935.

https://doi.org/10.1182/blood.V126.23.2935.2935

Published: 2015

Journal Articles

Disease Progression and Complications Are the Main Cause of Death in Patients with Chronic Lymphocytic Leukemia (CLL) Independent of Age and Comorbidities at Diagnosis

Paolo Strati, MD, Kari Chaffee, Sara Achenbach, Susan M. Schwager, Timothy G. Call, MD, Neil E. Kay, MD, James Cerhan, MD PhD, Susan L. Slager, PhD, Tait D. Shanafelt, MD

Blood (2015) 126 (23): 5265.

https://doi.org/10.1182/blood.V126.23.5265.5265

Published: 2015

Journal Articles

Pure Red Cell Aplasia (PRCA) in Chronic Lymphocytic Leukemia (CLL): Etiology, Therapy, and Outcomes

Mazie Tsang, MD, Kari Rabe Chaffee, MS, Timothy G. Call, MD, Wei Ding, MD PhD, Jose F. Leis, MD PhD, Asher Chanan-Khan, MD, Michael Conte, PA-C, Deborah A. Bowen, APRN, CNP, Susan M. Schwager, Susan L. Slager, PhD, Neil E. Kay, MD, Tait D. Shanafelt, MD, Sameer A. Parikh, MD

Blood (2015) 126 (23): 4169.

https://doi.org/10.1182/blood.V126.23.4169.4169

Published: 2015

Journal Articles

Busulfan for the Treatment of Myeloproliferative Neoplasms: The Mayo Clinic Experience

Kebede H. Begna, MD, Amro Abdelatif, MD, Susan M. Schwager, Curtis A. Hanson, MD, Animesh Pardanani, MBBS, PhD, Ayalew Tefferi, MD

Blood (2015) 126 (23): 4078.

https://doi.org/10.1182/blood.V126.23.4078.4078

Published: 2015

Journal Articles

The Importance of Pharmacovigilance during Ibrutinib Therapy for Chronic Lymphocytic Leukemia (CLL) in Routine Clinical Practice

Heidi D. Finnes, PharmD, Kari G. Chaffee, MS, Timothy G. Call, MD, Wei Ding, MD PhD, Deborah A. Bowen, APRN, CNP, Michael Conte, PA-C, Kristen B. McCullough, PharmD, Julianna A. Merten, PharmD, Gabriel T. Bartoo, PharmD, Matthew D. Smith, PharmD, Susan M. Schwager, Susan L. Slager, PhD, Neil E. Kay, MD, Tait D. Shanafelt, MD, Sameer A. Parikh, MD

Blood (2015) 126 (23): 717.

https://doi.org/10.1182/blood.V126.23.717.717

Published: 2015

Journal Articles

Atrial Fibrillation in Patients with Chronic Lymphocytic Leukemia (CLL)

Tait D. Shanafelt, MD, Kari G. Chaffee, MS, Timothy G. Call, MD, Sameer A. Parikh, MD, Susan M. Schwager, Wei Ding, MD PhD, Jose F. Leis, MD PhD, Asher Chanan-Khan, MD, Susan L. Slager, PhD, Neil E. Kay, MD

Blood (2015) 126 (23): 2950.

https://doi.org/10.1182/blood.V126.23.2950.2950

Published: 2015

Journal Articles

Correlation Between Peripheral Blood Counts and Extent of Bone Marrow Infiltration in Chronic Lymphocytic Leukemia

Wei Ding, MD PhD, Sara J Achenbach, Kari G. Chaffee, MS, Timothy G. Call, MD, Sameer A. Parikh, MD, Susan M. Schwager, Jose F. Leis, MD PhD, Asher Chanan-Khan, MD, Deborah A. Bowen, APRN, CNP, Michael Conte, PA-C, Susan L. Slager, PhD, Kay Medina, PhD, Neil E. Kay, MD, Tait D. Shanafelt, MD

Blood (2015) 126 (23): 2926.

https://doi.org/10.1182/blood.V126.23.2926.2926

Published: 2015

Journal Articles

The efficacy of ibrutinib in the treatment of Richter syndrome

Mazie Tsang, Tait D. Shanafelt, Timothy G. Call, Wei Ding, Asher Chanan-Khan, Jose F. Leis, Grzegorz S. Nowakowski, Deborah Bowen, Michael Conte, Susan M. Schwager, Susan L. Slager, Neil E. Kay, Curtis A. Hanson, Sameer A. Parikh

Blood (2015) 125 (10): 1676–1678.

https://doi.org/10.1182/blood-2014-12-610782

Published: 2015

Journal Articles

Platelet-derived growth factor (PDGF)–PDGF receptor interaction activates bone marrow–derived mesenchymal stromal cells derived from chronic lymphocytic leukemia: implications for an angiogenic switch

Wei Ding, Traci R. Knox, Renee C. Tschumper, Wenting Wu, Susan M. Schwager, Justin C. Boysen, Diane F. Jelinek, Neil E. Kay

Blood (2010) 116 (16): 2984–2993.

https://doi.org/10.1182/blood-2010-02-269894

Published: 2010

Includes: Supplemental data

NARROW

Outcomes of Patients with Chronic Lymphocytic Leukemia (CLL) Treated with the Combination of Ibrutinib (I) and Venetoclax (V; I+V) after Progression on I Alone (V-naïve) or after Progression on Sequential I and V (Double-Refractory)

The CLL International Prognostic Index predicts outcomes in monoclonal B-cell lymphocytosis and Rai 0 CLL

Venetoclax Has Modest Efficacy in the Treatment of Patients with Relapsed T-Cell Prolymphocytic Leukemia

Clinical Characteristics and Outcomes of Newly Diagnosed Patients with Chronic Lymphocytic Leukemia Who Are 80 Years of Age or Older

Impact of Deletion6q23 Identified By FISH in Patients with Chronic Lymphocytic Leukemia

BTK and/or PLCG2 Mutations in Patients with Chronic Lymphocytic Leukemia (CLL) Treated with Ibrutinib: Characteristics and Outcomes at the Time of Progression

The Role of Imaging in Predicting Time to First Treatment and Overall Survival in Individuals with CLL-like High Count Monoclonal B-Cell Lymphocytosis

Clinical Characteristics and Outcomes of Chronic Lymphocytic Leukemia Patients with Richter Transformation

The Role of Splenectomy in the Care and Treatment of the CLL Patient

Liver Dysfunction in Previously Untreated Chronic Lymphocytic Leukemia: Prevalence and Outcomes in a Large Cohort

Clinically Ascertained Monoclonal B-Cell Lymphocytosis: Risk of Progression to Chronic Lymphocytic Leukemia Requiring Therapy and Outcomes

Ibrutinib Therapy for Chronic Lymphocytic Leukemia (CLL): An Analysis of a Large Cohort of Patients Treated in Routine Clinical Practice

Disease Progression and Complications Are the Main Cause of Death in Patients with Chronic Lymphocytic Leukemia (CLL) Independent of Age and Comorbidities at Diagnosis

Pure Red Cell Aplasia (PRCA) in Chronic Lymphocytic Leukemia (CLL): Etiology, Therapy, and Outcomes

Busulfan for the Treatment of Myeloproliferative Neoplasms: The Mayo Clinic Experience

The Importance of Pharmacovigilance during Ibrutinib Therapy for Chronic Lymphocytic Leukemia (CLL) in Routine Clinical Practice

Atrial Fibrillation in Patients with Chronic Lymphocytic Leukemia (CLL)

Correlation Between Peripheral Blood Counts and Extent of Bone Marrow Infiltration in Chronic Lymphocytic Leukemia

The efficacy of ibrutinib in the treatment of Richter syndrome

Platelet-derived growth factor (PDGF)–PDGF receptor interaction activates bone marrow–derived mesenchymal stromal cells derived from chronic lymphocytic leukemia: implications for an angiogenic switch

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only